New CJEU decision on parallel importation of medicinal products: a victory for trademark owners
The decision confirms that repackaging may take place only where it is “objectively necessary” according to the BMS conditions.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10